WGS - GeneDx Holdings Corp.

88.84
-5.670   -6.382%

Share volume: 604,310
Last Updated: 03-10-2026
Healthcare/Services – Health: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$94.51
-5.67
-0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
44%
Profitability 35%
Dept financing 27%
Liquidity 50%
Performance 55%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.83%
1 Month
-2.84%
3 Months
-42.82%
6 Months
-29.43%
1 Year
1.92%
2 Year
857.33%
Key data
Stock price
$88.84
P/E Ratio 
0.00
DAY RANGE
$88.40 - $94.87
EPS 
-$0.73
52 WEEK RANGE
$55.17 - $170.87
52 WEEK CHANGE
-$3.52
MARKET CAP 
3.759 B
YIELD 
N/A
SHARES OUTSTANDING 
29.289 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.18
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$925,773
AVERAGE 30 VOLUME 
$815,608
Company detail
CEO: Katherine A. Stueland
Region: US
Website: sema4.com
Employees: 1,200
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Sema4 Holdings Corp. operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle.

Recent news